Immune Design Corp. (NASDAQ:IMDZ) Posts Basic Consolidated EPS Of $-2.0591

0

Immune Design Corp. (NASDAQ:IMDZ)managed to report annual basic consolidated EPS of $-2.0591, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-2.0591 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.7118.

EPS contribution from parent

Immune Design Corp. (NASDAQ:IMDZ) received of $-2.0591 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Immune Design Corp. (NASDAQ:IMDZ) contributed EPS of $-2.0591 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-2.0591.

What About Basic net EPS

The basic net EPS that Immune Design Corp. (NASDAQ:IMDZ) reported for the year ended 2015-12-31 stood at $-2.06. For the quarter ended 2015-12-31, the company posted basic net EPS of $-2.06.

What About Consolidated Diluted EPS?

Immune Design Corp. (NASDAQ:IMDZ)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-2.0591. For the quarter ended 2015-12-31 the metric was$-2.0591.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-2.0591 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-2.0591.

Net diluted EPS

Net diluted EPS posted by Immune Design Corp. (NASDAQ:IMDZ) for the year ended 2015-12-31 was $-2.06. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-2.06.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Immune Design Corp. (NASDAQ:IMDZ) said that it parent company boosted its diluted EPS by$-2.0591 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-2.0591.

The company reported net basic EPS of $-2.06 for the year ended 2015-12-31 and net basic EPS of $-2.06 for the quarter ended 2015-12-31.

The number of Immune Design Corp. (NASDAQ:IMDZ)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 19.156. That compares with 19.156 basic shares outstanding for the quarter ended 2015-12-31.

Immune Design Corp. (NASDAQ:IMDZ) had 19.156 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 19.156.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 17 times, 1 visits today)